Auxilium Pharmaceuticals, Inc. (AUXL) Posts Q1 Loss of 39c/Share

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/11/2026

1. HUM
2. SPCX
3. ALHC
4. PEP
5. T
6. TMUS
7. SPY
8. CVS
9. UNH
10. DAL

Go back to Auxilium Pharmaceuticals, Inc. (AUXL) Posts Q1 Loss of 39c/Share

Aegis Capital Sees Post-Q1 Pullback in Auxilium Pharma (AUXL) as Possible Entry Point

May 5, 2014 11:31 AM EDT

Aegis Capital affirms its Buy rating and $37 price target on Auxilium Pharmaceuticals (Nasdaq: AUXL) following Q1 results.

Analyst Ram Selvaraju commented, In our view, Auxilium's first quarter results were clearly a substantial disappointment, but we believe that the issues were restricted primarily to a significant miss on Testim revenues. Previously, Auxilium had expected $39mm in Testim sales based on IMS Health prescription data; the actual number was only $11mm. The firm's top-line revenues in 1Q 2014 came in at $88.5mm, well behind our... More